Description

At GLP1 Peptides, we provide the scientific community with professional-grade tools for advanced biochemical research. KPV 10mg is a potent tripeptide recognized for its ability to modulate the inflammatory response without the pigment-inducing effects associated with the full $\alpha$-MSH molecule.

The 10mg vial format is ideal for researchers investigating the molecular pathways of the innate immune system. Researchers utilize KPV to investigate:

• NF-$\kappa$B Inhibition: Studying the reduction of pro-inflammatory cytokine expression by interfering with nuclear factor-kappa B signaling.

• Antimicrobial Properties: Researching the peptide’s direct interaction with pathogenic microorganisms, including Candida albicans and Staphylococcus aureus.

• Intestinal Homeostasis: Investigating the peptide’s role in reducing colonic inflammation and protecting the integrity of the intestinal mucosal barrier.

• Dermatological Inflammation: Studying the modulation of allergic and inflammatory responses within the skin’s microenvironment.

The GLP1 Peptides Quality Standard

• Verified 99% Purity: Every batch of KPV 10mg is verified through HPLC and Mass Spectrometry to ensure a purity rating of 99% or higher.

• Advanced Lyophilization: Our professional freeze-drying process protects the Lys-Pro-Val sequence, ensuring long-term shelf stability and a reliable research tool for your laboratory.

• Analytical Transparency: We provide a batch-specific Certificate of Analysis (COA) with every order, ensuring researchers have full data integrity for their records.

• Synthesis Precision: Our protocols prioritize exact molecular sequencing to provide a consistent and reliable research analog for institutional studies.

Technical Product Specifications:

• Compound Name: KPV

• Sequence: Lys-Pro-Val

• Molecular Formula: $C_{16}H_{30}N_{4}O_{4}$

• Molecular Weight: 342.43 g/mol

• Purity Rating: >99%

• Format: White Lyophilized Powder

• Storage Requirements: Store at -20°C for optimal long-term stability and potency.